Explore

Trendline Trendline
Alpha Cognition to Announce Q1 2026 Financial Results and Business Update

Alpha Cognition to Announce Q1 2026 Financial Results and Business Update

Alpha Cognition to Announce Q1 2026 Financial Results and Business Update
Trendline Trendline
Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology

Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology

Merck Discontinues Early-Stage TROP ADC Amid Strategic Shifts in Oncology
Trendline Trendline
Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Trendline Trendline
Prilenia Appoints Dr. Elisabeth Leiderman as CFO to Advance Neurodegenerative Disease Research

Prilenia Appoints Dr. Elisabeth Leiderman as CFO to Advance Neurodegenerative Disease Research

Prilenia Appoints Dr. Elisabeth Leiderman as CFO to Advance Neurodegenerative Disease Research
Trendline Trendline
Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership

Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership

Pharmaceutical Companies Announce Key Board Appointments to Strengthen Leadership
Trendline Trendline
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
Trendline Trendline
GSK and Alector Halt Alzheimer's Drug Trial After Efficacy Failure

GSK and Alector Halt Alzheimer's Drug Trial After Efficacy Failure

GSK and Alector Halt Alzheimer's Drug Trial After Efficacy Failure
Trendline Trendline
Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy
Trendline Trendline
DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026
Trendline Trendline
Avalyn Pharma Aims for $300 Million in IPO to Advance Inhaled Therapies for Lung Diseases

Avalyn Pharma Aims for $300 Million in IPO to Advance Inhaled Therapies for Lung Diseases

Avalyn Pharma Aims for $300 Million in IPO to Advance Inhaled Therapies for Lung Diseases
Trendline Trendline
Soligenix Halts Phase 3 Trial of HyBryte for Cutaneous T-Cell Lymphoma Due to Futility

Soligenix Halts Phase 3 Trial of HyBryte for Cutaneous T-Cell Lymphoma Due to Futility

Soligenix Halts Phase 3 Trial of HyBryte for Cutaneous T-Cell Lymphoma Due to Futility